AURA BIOSCIENCES, INC. AURA 深 滬
等待開盤 12-12 09:30:00 美东时间
6.51
+0.040
+0.62%
華盛通- 最 高6.55
- 今 開6.47
- 成交量 16.41万股
- 最 低 6.3837
- 昨 收 6.47
- 總市值 4.13亿
- 52周最高 8.60
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.345
- 委 比 -14.04%
- 總股本 6350.33万
- 歷史最高 26.16
- 量 比 1.26
- 振 幅 2.57%
- 歷史最低 4.345
- 每 手 1
- 風險率 0.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Aura Biosciences Q3 EPS $(0.40) Beats $(0.47) Estimate
Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.47) by 14.53 percent. This is a 4.76 percent increase over losses of $(0.42) per share from
11-13 20:12
x402 Is Exploding Across DeFi. Here's Why Smart Money Is Paying Attention
Coinbase's new micropayments protocol is a bold bet on an AI-powered crypto economy.
10-30 20:29
Aura Announces Preliminary Q3 2025 and 9M 2025 Production Results, Reaching Record Highs
Aura Minerals reported strong Q3 2025 production, reaching 74,227 GEO, up 16% from Q2 2025 and 9% from Q3 2024. CEO Rodrigo Barbosa highlighted record performance and the successful launch of Borborema mine. Key mines showed varied results: Aranzazu dipped 3% due to metal prices, Minosa remained stable, Almas rose 17% from expansion, Apoena increased 13% with higher recovery rates, and Borborema exceeded 10,000 ounces. Year-to-date production sta...
10-10 10:00
9500F配什么主板合适？
【ZOL中关村在线原创导购】前段时间，AMD正式推出了新一代Zen5架构的锐龙5 9500F处理器。这款处理器主打入门游戏，采用了全新Zen5架构，使用先进的台...
10-04 07:12
Bitcoin Breaks $121,000; Ethereum, Dogecoin, XRP Also Extend Gains: Analytics Firm Says BTC Rally To $130,000 'Appears Realistic'
Leading cryptocurrencies and stocks rose higher on Thursday, as investors shrugged off government shutdown concerns.
10-03 10:05
Incentive Program for the Conversion of BDRs into Shares
Aura Minerals Inc. has announced an Incentive Program allowing holders of its Brazilian Depositary Receipts (BDRs) to convert their BDRs into common shares listed on Nasdaq at a 3:1 ratio without fees. The program runs from October 6 to November 6, 2025. Each holder may submit only one conversion request, and subsequent conversions will incur fees. The company aims to increase trading activity on Nasdaq through this initiative, with no expected i...
10-02 11:00
Advancing Cancer Research Brings New Hope for Patients Worldwide
NetworkNewsWire Editorial Coverage NEW YORK, Sept. 17, 2025 /PRNewswire/ -- Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical...
09-17 20:30
7点！医械早播报-9/17
（来源：医疗器械创新网） 01 监管政策与招投标 上海发布高端医疗器械产业全链条发展行动方案 2025 年 9 月 4 日印发，目标 2027 年新增境内三类医...
09-17 07:00
4年、刷新中位OS纪录，奥希替尼与阿斯利康开启肺癌长生存新篇章
（来源：氨基观察） 每年9月，全球肺癌领域的目光都会聚焦于同一盛会——世界肺癌大会（WCLC）。如何从更多免疫、靶向联合治疗策略中，进一步提升疗效和生存获益是...
09-15 18:44
OS为尺，衡量肿瘤药真章：4年OS，阿斯利康如何脱颖而出？
（来源：药剂Talks） 近期，FDA发布了《肿瘤临床试验中总生存期评估方法指南草案》，首次系统明确总生存期（OS）在随机对照试验中的核心地位及其具体操作规范...
09-13 09:01
